Replies to post #75815 on Blue Diamond Ventures Inc (BLDV)

[Rhinegold]

Now I like that! I stickied it. Great post! $BLDV

[gwat1979]

Awesome update! 20M bidder at .001 atm

[YogitheBear]

Awesome! SQUEEZE those Illegal Naked SHORTS!! Going back to a Penny & Higher!!

[GreenKnight]

LOVELY! Go BLDV

[stervc]

BLDV & Cann10 North America News of Merging...

This is good news for BLDV with having BLDV and Cann10 North America merge into being a single operational entity. The news suggests that doing this is going to culminate in the growth of AMS too:

https://backend.otcmarkets.com/otcapi/company/dns/news/document/30667/content


BLDV and Cann10 North America Discuss Merging Operations

Blue Diamond Ventures Inc. would become SEC Reporting and Expand Governance

April 20th, 2018 – Blue Diamond Ventures Inc, (OTC PK: BLDV) Chicago, IL.

Cann10 North America Holdings LTD. and Blue Diamond Ventures Inc.
consider the benefits of a Merger.

Cann10 North America and BLDV revealed today that part of the initial
share purchase agreement, signed in December, includes a path to merge the companies into a single stronger entity.

The potential deal would be one of the first mergers into an operating OTC PK company in the cannabis industry and although the “Triple Package” of Foreign ownership, Non-Reporting Pink Sheet, and Marijuana make for a bit of complication, the Biotech access that comes with Cann10 make it worth the effort.

“One year ago, today, we announced our entrance to the Cannabis Space with a Strategic Partnership with AMS” says Josh Alper, BLDV CEO. “Today our partnership with Cann10 allows us to deliver a sustainable competitive advantage to AMS and other companies through the Cann10 Alliance. The Alliance will deliver Israeli Cannabis Technology and Innovation from Israel to North America, the partnership with AMS has remained central to this process and when the export from Israel opens up, we will deliver on the original promise to combine forces with AMS as well.”.

A new product line “Cannareet” was released this week in Israel by Cann10, these formulations were created in the Cann10 Labs and represent the latest combination of GMP manufacturing and strict Israeli approvals that will be made available to the Global Market.

About BLDV:

Blue Diamond Ventures, Inc. is a diversified customer centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in medical cannabis markets and is driven by critical thinking, the scientific method and compassionate ways to deliver sustainable results

About Cann10:

Cann10 is one of the Leading Medical Cannabis Groups in Israel. They create and produce highly recognized Professional Cannabis Education Programs, including the CannX Medical Conferences in Israel, and the Cann10 XL a focused accelerator, offering selected entrepreneurs the advantages of high quality infrastructures, facilities, team, network, know-how and professional mentoring, tailored to support successful development, fund raising and commercialization of new technologies in this emerging field. A collaboration between a leading Israeli authorized medical cannabis farm, and a leading Israeli holding and services group, Cann10 combines the respective expertise in the fields of medical cannabis and commercialization of medical devices and drugs, to support the introduction of new high value related products.

Contact:
Blue Diamond Ventures Inc. / Cann10 North America
535 N. Michigan Avenue, Suite 3001, Chicago, Illinois, 60611
Joshua B. Alper Chief Executive Officer BLDV – Managing Director of Cann10 NA
[phone] [e-mail] www.bldvinc.com

v/r
Sterling

[JPS02]

Cann10 - Our Activities

http://www.cann10.com/our-activities

Intelligent investing

In a business that is still considered by many to be extremely risky, there are many excellent opportunities to earn significant returns on investment. It all depends on who you invest with and what you are investing in. Seeach Farm, a Cann10 partner, has been successfully operating in medical cannabis business for years. Cann10 has its own license, from the Israel Ministry of Health, to manufacture medical cannabis products. We also work around the world, so our outlook is global.

Cann 10 doesn’t just talk about medical cannabis. We are involved every step of the way. For intelligent investing, speak to those in the business – and in the know.

Source: http://www.cann10.com/our-activities/#Intelligent

Global Trade

Medical Cannabis is breaking down borders and becoming an important trade commodity. Cann10 is uniquely positioned to help fill supply gaps with top quality GMP-approved product from around the world. Thanks to our experience in the pharma world, we are aware of global requirements for shipping, licensing, trading and regulatory issues. We can save time, money and hassle and ensure you open new markets or get the high product you require.

Cann10 is currently developing new farms and production facilities in Europe, North America, Asia and Australia to supply everything from CBD and THC or CBD only, flowers to oils, tables to vaps. We are also developing our own branded line of Cannareet -products that will carry the approval GMP and all necessary local certification.

If you are a distributor, produce medical cannabis or require product, please contact us so we can meet your most demanding criteria.

Source: http://www.cann10.com/our-activities/#Global

Education Services

Although the world of medical cannabis is rapidly expanding, there is a lack of professional education available for those involved in growing, producing, prescribing and monitoring patients.

Joint University Programs

Cann10 has and continues to establish connections with leading universities to provide high-level courses for a wide range of students including investors, lawyers, accountants, entrepreneurs, physicians, pharmacists, nurses, farmers, and producers. Currently, we offer certificate courses with Israel’s famed Technion and Australia’s Deakin University. This 32 hour course covers everything from plant physiology, growing, farming, medical knowledge, science, technology, marketing, branding, regulations, patient care and more.

Cann10 is interested in working with other leading universities. We provide the course content and the partner university provides lecturers and localizes content. For more information please contact us

Professional Education CME

Cann10 is offers specialized and accredited courses for Physicians, Pharmacists, Nurses and Care Givers. Attendees will earn CME credits and gain valuable insight into the advances, dosing and treatment of patients. For more information, please contact us.

E-learning

Cann10 is currently developing a number of e- learning courses. These will include a variety of modules that can be used on a mobile phone or laptop .

Source: http://www.cann10.com/our-activities/#Education


- I think the above activities descriptions available on Cann10's website strongly demonstrate the depth of knowledge and expertise that BLDV can have access to through Cann10 North America to help support its strategic partners.

Go BLDV!